BioCentury
ARTICLE | Clinical News

Avandamet combination of rosiglitazone and metformin regulatory update

October 14, 2002 7:00 AM UTC

FDA granted marketing approval to GSK for its Avandamet to treat Type II diabetes. The use of rosiglitazone tablets with separate metformin tablets was approved by FDA in 1999. Rosiglitazone is market...